202 companies found.  = FIB member |
|---|
| Company | Contact information | Activities |
|---|
4Pharma Ltd
Lemminkäisenkatu 1, FI-20520 Turku, Finland
Web site: www.4pharma.com
Founded: 2002
Personnel: 15 (2004) | Marko Suojanen, Executive Vice President
Phone: +358 44 029 7796
Fax: +358 2 283 5701
marko.suojanen(at)4pharma.com Jari Turunen, Vice President, Technology
Phone: +358 44 029 7783
Fax: +358 2 283 5701
jari.turunen(at)4pharma.com | R&D activities: Local, world-class services in statistics, data management, data warehousing and medical writing. A wide variety of expertise in information technology, international regulatory affairs and pharmaceutical R&D overall. Categories of activity: Biotech support company; R&D service; Other service; |
AB Enzymes Oy
PO Box 26, FIN-05201 Rajamäki, Finland
Web site: www.abenzymes.com
Founded: 1997
Turnover: EUR 2,2 million (2004)
Personnel: 14 (2004) | Ralf Lundell, Managing Director
Phone: +358 9 2902 2510
Fax: +358 9 2902 2550
ralf.lundell(at)abenzymes.fi Pentti Ojapalo, Textile Group Manager
Phone: +358 9 2902 2515
Fax: +358 9 2902 2550
pentti.ojapalo(at)abenzymes.fi | R&D activities: Development of technical enzyme applications. Core technologies: Technical enzymes for use in following industrial areas of application: detergent, textile, pulp and paper, animal feed. Categories of activity: Biotech company; Production; R&D; Enzymes; |
Abacus Diagnostica Oy
| | Categories of activity: |
Abcell Oy
PO Box 62, FI-33101 Tampere, Finland
Web site: www.abcell.fi
Founded: 1990 | Terho Eloranta, Managing Director
Phone: +358 50 569 6986 +
Fax: +358 3 265 6213
abcell(at)kolumbus.fi | Production (and other) activities: Manufacturer of the unique AB-MAX Plasma Cell Growth supporters keeping antibody-producing B lymphocytes alive and rescuing dying hybridomas. Custom-tailored production of hybridoma cell lines, monoclonal and polyclonal antibodies, antisera and hen antibodies. Distributor services of IVD and research instruments, reagents and materials. Categories of activity: Biotech company; Production; Other service; Supplier; Diagnostics and devices; Research reagents; |
Aboatox Oy
Lemminkäisenkatu 36, FI-20520 Turku, Finland
Web site: www.aboatox.com
Founded: 2001
Personnel: 1 (2007) | Juha Lappalainen, PhD, Managing Director
Phone: +358 2 2410 244
Fax: +358 2 2410 246
juha.lappalainen(at)aboatox.com | Production (and other) activities: Production of toxicitymonitoring tests based on photobacterium Vibrio fischeri and Genetically Engineered Heavy Metal Biotests. Sales of luminometers and chemicals for luminescence analysis (ATP, reporter gene). Hygiene monitoring kits and instruments. Microscale environmental toxicity tests based on maintenance free Microbiotests. R&D activities: Improved use and new applications of luminescent bacteria. Kinetic measurement with photobacteria. Core technologies: Luminometry. Categories of activity: Biotech company; Production; R&D; Food and feed; Environment; |
Afore Oy
| | Categories of activity: |
Aicons Oy
| | Categories of activity: |
Ailab Solutions Oy
Eteläinen Makasiinikatu 4, FIN-00130 Helsinki, Finland
Web site: www.ailabsolutions.com
Founded: 2000
Personnel: 6 | Ari Aalto, CEO
Phone: +358 400 801166
Fax: +358 9 6852030
ari.aalto(at)ailabsolutions.com Dr Tommi Rakshit, Business Development
Phone: +358 40 585 6185
Fax: +358 9 685 2030
tommi.rakshit(at)ailabsolutions.com | Production (and other) activities: Our intelligent algorithms solve complex optimization, prediction and classification problems. They can handle hundreds of parameters and massive databases. The applications range from predicting molecule activity to modelling metabolic fluxes. R&D activities: We have more than ten joint R&D project with companies and university groups. The projects result new intelligent software tools for scientists and patentable scientific discoveries. Core technologies: All intelligent computational technologies including genetic algorithms, neural networks and support vector machines. Categories of activity: Biotech company; Bioinformatics; |
Alimetrics Ltd
| | Categories of activity: |
Alkomohr Biotech Oy Ltd
Lehtotie 8, FIN-00630 Helsinki, Finland
Founded: 1995
Personnel: 3 | Dr Matti Korhola, Managing Director
Phone: +358 50 562 6903
Fax: +358 9 728 3937
matti.korhola(at)yeast.pp.fi | R&D activities: Research, product and process development on industrial enzymes and yeasts. Core technologies: Baker's, brewer's, distiller's, sour dough, and wine yeast strain improvement by classical genetic breeding and by genetic engineering. Proprietary enzyme application technology. Categories of activity: Biotech support company; Other service; Enzymes; |
Ani Biotech Oy
| | Categories of activity: |
Ani Labsystems Oy Ltd
Tiilitie 3, FI-01720 Vantaa, Finland
Web site: www.anilabsystems.com
Founded: 2002
Turnover: EUR 3 million (2005)
Personnel: 28 (2005) | Ilari Tuominen, Marketing Manager
Phone: +358 40 518 6515
Fax: +358 20 155 7521
ilari.tuominen(at)anilabsystems.com Aimo Niskanen, Managing Director
Phone: +358 400 454 020
Fax: +358 20 155 7521
aimo.niskanen(at)anibiotech.fi | Production (and other) activities: Diagnostic EIA kits and reagents for use in clinical and research laboratories. Main areas of interest: infectious diseases and neonatal screening. Latest product launches in 2005: EIA tests for Celiac disease and 17-OHP. R&D activities: New generation EIA kits for respiratory infections, other infectious diseases, gastrology problems, hormone detection, blood screening and neonatal screening. Core technologies: EIA, FEIA, MIF. Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices; Biomaterials; Research reagents; |
APL Systems Oy
| | Categories of activity: |
ArcDia Ltd.
Tykistökatu 6, 20521 Turku, PL51
Web site: www.arcdia.com
Founded: 1993
Turnover: EUR 0,5 million (2006)
Personnel: 5 (2006) | Erkki Soini, CEO
Phone: +358-400-20643
Fax: 02-4544159
erkki.soini(at)arcdia.com | Production (and other) activities: technology R&D and licensing R&D activities: in vitro diagnostics Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Arctic Diagnostics Oy
Tykistökatu 6, FIN-20520 Turku, Finland
Web site: www.arcdia.com
Founded: 1993
Turnover: EUR 1 million
Personnel: 10 | Erkki Soini
Phone:
Fax: +358 2 2637 1250
info(at)arcdia.com | R&D activities: Biotechnology research and development and licensing. Core technologies: Two-photon fluorescence excitation technology. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Ark Therapeutics Oy
Neulaniementie 2 L, FI-70210 Kuopio, Finland
Web site: www.arktherapeutics.com
Founded: 1993
Turnover: EUR 5 million (2005)
Personnel: 80 (2005) | Timo Ristola, General Manager
Phone: +358 17 240 879
Fax: +358 17 240 876
timo.ristola(at)arktherapeutics.com Matti Lähde, Production Manager
Phone: +358 17 240 873
Fax: +358 17 240 876
matti.lahde(at)arktherapeutics.com | Production (and other) activities: Company's business involved during the financial period of year 2002 research, product development and manufacturing of gene based medicine, diagnostic products and new vector development for clinical experiments. Investment in research and product development will be raised further onwards. Company plans to secure production capacity suitable for late stage clinical development and commercialization. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Aromtech Ltd
Veturitallintie 1, FIN-95410 Kiviranta/Tornio, Finland
Web site: www.aromtech.com
Founded: 1991
Turnover: EUR 2 million (2006)
Personnel: 13 (2006) | Dr Vesa-Pekka Judin, Managing Director
Phone: +358 40 742 9639
Fax: +358 207 789 029
vesa-pekka.judin(at)aromtech.com Mr Veli-Markku Korteniemi, Chairman of the Board
Phone: +358 400 392 494
Fax: +358 207 789 028
veli-markku.korteniemi(at)aromtech.com | Production (and other) activities: Marketing and manufacture of food supplements, as well as ingredients for cosmetics and functional foods R&D activities: Development of natural active ingredients for nutrition and cosmetics. Core technologies: Supercritical CO2 extraction
Sea buckthorn: abundance, chemistry, processing, clinical trials/physiological effects
Sourcing of highly functional natural ingredients of northern origin Categories of activity: Biotech support company; Production; R&D; Food and feed; |
Avenly Oy
Pohjanpellontie 16 D, FI-00780 Helsinki, Finland
Web site: www.avenly.fi
Founded: 1998
Personnel: <1 (2006) | Hannu Salovaara, Chairman of Board
Phone: +358 400 417792
Fax:
hannu.salovaara(at)avenly.fi | Production (and other) activities: Avenly Oy (Ltd.) studies and develops traditional foods processes to meet todays needs.
The company has licensed out technology for an oat bran based alternative to dairy or soy yogurts.
A commercially successful product has been on the market in Finland for several years.
In the process, fermentation occurs, using probiotic bacteria. The substrate is high in functional oat beta-glucan. Both components, the probiotic bacteria and the soluble oat fibre provide health claim potential. Core technologies: Oat bran, fermentation. Categories of activity: Biotech support company; R&D; Other service; Food and feed; |
Bayer Oy
Bayer CropScience
Suomalaistentie 7, FI-02270 Espoo, Finland
Web site: www.bayercropscience.com
Personnel: 1 | Kari Puukko, Sales Manager
Phone: +358 9 887 8433 and
Fax: +358 9 887 8703
kari.puukko(at)bayercropscience.com | Production (and other) activities: Markets crop protection products. Categories of activity: Biotech support company; Supplier; Agro; |
BBS Bioactive Bone Substitutes Oy
| | Categories of activity: |
BCB Medical Ltd.
| | Categories of activity: |
Bio Fund Management Oy Ltd
Mikonkatu 4, 3rd floor, PO Box 164, FI-00101 Helsinki, Finland
Web site: www.biofund.fi
Founded: 1997
Personnel: 11 (2007) | Erkki Pekkarinen, President, Partner
Phone: +358 9 251 44 613
Fax: +358 9 251 44 620
erkki.pekkarinen(at)biofund.fi Kalevi Kurkijärvi, Senior Partner, Chairman of the Board & CEO
Phone: +358 9 251 44 611
Fax: +358 9 251 44 620
kalevi.kurkijarvi(at)biofund.fi | Production (and other) activities: Bio Fund Management Oy Ltd is one of the leading European venture capital management companies investing solely in life sciences. The main sectors include pharmaceuticals and therapies, medical technologies (medtech), cleantech and nutrition. BioFund's investment focus is exclusively on minority equity interests. BioFund makes investments solely in unlisted growth companies. In addition to early stage investments BioFund may also invest in expansion capital, turn-around and restructuring as well as MBO's and MBIs. BioFund is headquartered in Helsinki, Finland and maintains an office in Turku and in Copenhagen, Denmark. BioFund's ventures are concentrated in Europe, particularly in the Nordic countries. Categories of activity: Biotech support company; |
Bio-Nobile Oy
Tykistökatu 4 b, PO Box 36, FIN 20520 Turku, Finland
Web site: www.bio-nobile.com
Founded: 96
Personnel: 12 | Stefan Järnström, Managing Director
Phone: +358 2 410 1101
Fax: +358 2 410 1123
stefan.jarnstrom(at)bio-nobile.com | Production (and other) activities: Bio-Nobile develops, produces, markets and sells products for nucleic acid and protein purification. Product range comprise PickPen magnetic tools, MagRo 8-M automatic sample purification workstation. A comprehensive range of purification kits and reagents are available in the QuickPick kit product range. R&D activities: Bio-Nobile is active in both method and technology research as well as application and product development. The R&D is done in house and in cooperation with a partner network. Core technologies: The PickPen method for magnetic particle processing. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Environment; |
Biocelex Oy
Lemminkäisenkatu 5 C, FI-20520 Turku, Finland
Web site: www.biocelex.com
Founded: 2007
Personnel: 3 (2007) | Kai Lahtonen, President & CEO
Phone: +358 50 689 48
Fax: +358 2 4788 488
kai.lahtonen(at)biocelex.com | Production (and other) activities: Biocelex Ltd is a privately-held international innovation and business development company offering services for the Life Sciences field. We focus on business and technology areas related to drug discovery & development, diagnostics, biomaterials, functional foods and life science services. Geographically we operate in Scandinavia and the Baltic Sea region, with a particular focus on Finland.
In terms of Innovation Development, Biocelex adapts and applies the world famous and proven process of one of its co-owners, Karolinska Institutet Holding AB. We evaluate, consult and develop promising innovation to start-ups with a possibility for early-stage funding.
Biocelex Ltd offers Business Development services for a broad range of Life Science companies. For growth phase companies, our experienced team can help you with e.g. strategy planning, product development and market entry. For established companies looking for new openings or additions to their product portfolio, we offer e.g. scouting services, due diligence or technical assessments and reports on the local operating environment.
Categories of activity: Biotech support company; Other service; |
BioChance Oy
Laivurinrinne 2 A 6, FIN-00120 Helsinki, Finland
Founded: 1998 | Marja-Liisa Huhtala, Managing Director
Phone: +358 9 68427900 and
Fax: +358 9 6842 7901
marja-liisa.huhtala(at)kolumbus.fi | Production (and other) activities: Develops immunoassay technology and syntehtic peptide and recombinant antigens for infectious diseases serology. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
BIOCID Oy Ltd
Teknobulevardi 3-5, PO Box 35, FI-01531 Vantaa
Web site: www.biocid.com
Founded: 2001
Turnover: EUR < 1 million
Personnel: 5 | Peter Christiansen, Managing Director
Phone: +358 40 508 0705
Fax: +358 9 2517 8101
peter.christiansen(at)biocid.com | Production (and other) activities: Oy BIOCID Ltd - advanced food hygiene technologies that offer an integrated service concept for optimizing production hygiene and improving operational quality in any food industry enterprise. Core technologies: BIOCID is not a traditional company in the biotechnology (microbiology and hygiene management) or electronics (electronic equipment and process control) sector, but rather represents an innovative combination of the two.BIOCID carries out design and production of electronic UVC irradiators, integrates systems, and supplies activated oxygen generators as well as control measuring and sensor technology. Categories of activity: Biotech company; Production; Other service; Diagnostics and devices; Food and feed; |
BioCis Pharma Oy
Pharmacity, Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.biocis.com
Founded: 2003
Personnel: 3 (2005) | Dr Lasse Leino, CEO
Phone: +358 40 8494 694
Fax: +358 2 4788 371
lasse.leino(at)biocis.com Dr Jarmo Laihia, R&D Director
Phone: +358 2 478 8378
Fax: +3582 478 8371
jarmo.laihia(at)biocis.com | R&D activities: Development of new drugs for inflammatory and cancer diseases. Core technologies: Drug development, photoimmunology, cis-urocanic acid based therapeutics. Categories of activity: Biotech company; R&D; Drug discovery; |
Bioclin Oy
| | Categories of activity: |
Biocomputing Platforms Ltd
Tekniikantie 14, FI-02150 Espoo, Finland
Web site: www.bcplatforms.com
Founded: 1997 | Pekka Mäkelä, Managing Director
Phone: +358 9 2517 7340
Fax: +358 10 296 1288
| Production (and other) activities: Marketing and development of data management solutions for genetic studies. Categories of activity: R&D service; Bioinformatics; |
Biodeus Oy
Lemminkäisenkatu 5C, FIN-20520 Turku, Finland
Web site: www.biodeus.com
Founded: 2000
Personnel: 5 | Jan Parkki
Phone: +358 400 536 835
Fax: +358 4 211 00 44
jan.parkki(at)biodeus.com | R&D activities: Biodeus develops new technology for protein purification. Categories of activity: Biotech company; R&D; |
Biofellows Oy
Koetilantie 1 C 18, FI-00790 Helsinki, Finland
Web site: www.biofellows.com
Founded: 1998
Turnover: EUR 2,5 million (2007)
Personnel: 8 (2007) | Mr Veli-Pekka Karvinen, Managing Director
Phone: +358 9 755 2550
Fax: +358 9 7552 5555
veli-pekka.karvinen(at)biofellows.com | Production (and other) activities: Distribution of molecular biology reagents and laboratory instruments. Categories of activity: Biotech support company; Supplier; Drug discovery; Diagnostics and devices; Enzymes; Research reagents; |
Bioferme Oy
Rauvolantie 64, FI-20760 Piispanristi, Finland
Web site: www.bioferme.fi
Founded: 1977
Turnover: EUR 2 million
Personnel: 11 | Merja Scharlin, Managing Director
Phone: + 358 2 276 2600
Fax: + 358 2 276 2621
merja.scharlin(at)bioferme.fi Reetta Myllymäki, Marketing Assistant
Phone: + 358 2 276 2600
Fax: + 358 2 276 2621
reetta.myllymaki(at)bioferme.fi | Production (and other) activities: Production Bioferme Oy manufactures Yosa and Yosa Plus oat products, fermented vegatable products and fruit/berry juices. Categories of activity: Biotech company; Production; Food and feed; |
Biofile Ltd
PO Box 450, FI-20101 Turku, Finland
Web site: www.biofilediagnostics.com
Founded: 1995 | Vesa Kleimola, CEO
Phone: + 358 2 481 81 00
Fax: + 358 2 481 81 01
vesa.kleimola(at)biofilediagnostics.com | Production (and other) activities: Biofile is a privately held Finnish company specialising in autoimmune disease and infectious disease diagnostics. The Company employs at the moment group of highly skilled and motivated professionals who develop and manufacture very sensitive and specific diagnostic test kits for gastroenterology autoimmune and infectious diseases. Biofile’s diagnostics products provide accuracy, simplicity and enable early disease diagnosis and treatment. All of Biofile's diagnostics products are used in procedures performed in vitro (outside the body) and enhance patient well being.
The current product portfolio of Biofile, based on well-known ELISA/IFA technologies, consists of a panel of six diagnostic kits for celiac disease, kit for helicobacter pylori testing and two kits for diagnosing Crohn's disease. Additionally the Company focuses also to the importing of certain autoimmune diagnostic kits to the Local market and surraounding markets, private labels some supporting diagnostic kits and runs a specialist clinical service laboratory. Clinical Laboratory helps the Company to keep in touch with customers and their needs today and in the future.
The Company has a strong background in research. Through its own personnel and scientific network Biofile has the technical expertise to enable research and product development efforts, in addition to celiac disease, in other autoimmune diseases as Crohn's disease, Colitis Ulcerosa and in infectious diseases as Helicobacter. Categories of activity: Biotech company; Production; Supplier; Diagnostics and devices; |
Bioforum Oulu
Kiviharjutie 11, FI-90220 Oulu, Finland
Web site: www.bioforumoulu.org
Personnel: 1 | Pirkko Suhonen, Programme Director
Phone: +358 44 521 2688
Fax: +358 8 5372011
pirkko.suhonen(at)medipolisgmp.com | Production (and other) activities: Bioforum Oulu is part of Oulu Region Center of Expertise Program and gathers together biotech companies, universities and R&D organisations in the Oulu region and stimulates their co-operation. Bioforum works closely with other players in the region and also carries out spearhead projects named in the Oulu Growth Agreement. The intent is to develop new products and services that enhance people's health and well-being and to create new business in the field. Core technologies: Diagnostics, bioprocessing, GMP production facilities, agrobiotechnology and BioIT. Categories of activity: Biotech centre; |
Biohit Oyj
Laippatie 1, FI-00880 Helsinki, Finland
Web site: www.biohit.com
Founded: 1988
Turnover: EUR 26,3 million (2003)
Personnel: 298 (2003) | Osmo Suovaniemi, President & CEO
Phone: +358 9 773 861
Fax: +358 9 773 86 205
osmo.suovaniemi(at)biohit.com | Production (and other) activities: Liquid handling: Electronic and mechanical pipettors, disposable pipettor tips, maintenance, calibration and training services. Diagnostics: Test panel (GastroPanel) for diagnosing Helicobacter pylori infection and atrophic gastritis as well as for screening the risk of gastric cancer, peptic ulcer, the reflux disease, and its complication, Barrett's oesophagus, from a blood sample. In addition, tests for the detection of lactose intolerance and systemic lupus erythematosus (SLE). Instruments: microplate readers, washers and related software, which support the performance and analysis of the results of the diagnostic tests. R&D activities: Liquid handling, diagnostics. Core technologies: Liquid handling, diagnostics, instruments, systems composed of the said product groups. Categories of activity: Biotech company; Production; Diagnostics and devices; |
Bioka Oy
Sokeritehtaantie 20, FI-02460 Kantvik, Finland
Web site: www.bioka.fi
Founded: 1992 | Paavo Lehtonen, Managing Director
Phone: +358 9 2230 2350
Fax: +358 9 2230 2350
paavo.lehtonen(at)kolumbus.fi | Production (and other) activities: Production Develops and manufactures enzyme based oxygen absorbers to be used in the packaging of food and pharmaceutical products. Core technologies: Oxygen absorbers Categories of activity: Biotech company; |
Biomarket Oy
Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.biomarket.fi
Founded: 2004
Personnel: 4 (2006) | Kari Kurki, Managing Director
Phone: +358 400 523 213
Fax: +358 2 478 8681
kari.kurki(at)biomarket.fi Arja Mannila, Margeting Manager
Phone: +358 50 3633 969
Fax: +358 2 478 8681
arja.mannila(at)biomarket.fi | Production (and other) activities: BioMarket Oy is a growing producer and distributor of diagnostic and molecular biology products for research groups, diagnostics industry and clinical laboratories.
BioMarket Oy offers more than 100 products in the field of infectious diseases, monoclonal antibodies, antigens,cardiac markers and CARD-i-KIT immunochromatographic IVD tests, extracellular matrix, integrin, endocrinology and molecular biology products including modifying enzymes and PCR. reagents. Categories of activity: Biotech company; Other service; Supplier; Diagnostics and devices; Enzymes; Research reagents; |
Biomedicum Genomics Oy
Haartmaninkatu 8, FI 00290 Helsinki, Finland
Web site: www.biomedicumgenomics.fi
Founded: 2007
Personnel: 5 (2008) | Dr. Outi Monni, Director
Phone: +358 40 763 9302
Fax:
outi.monni(at)helsinki.fi Anne Mäkelä, Project Manager
Phone: +358 9 191 256 31
Fax:
anne.makela(at)helsinki.fi | Production (and other) activities: BIOMEDICUM GENOMICS (BMGen) is a new functional genomics service provider operating at Biomedicum Helsinki. BMGen promotes nationwide biotechnology development by providing academic and industrial clients access to many functional genomics technologies and services. BMGen offers variety of biochip services for genome-wide expression, copy number profiling, miRNA expression, DNA-protein interaction (ChIP-on-chip) including e.g. RNA/DNA extraction and RNA quality assessment. For gene silencing and ectopic expression purposes, we offer high-titer shRNA or ORF lentiviruses targeting genes of interest. We also offer customized services e.g. preparation of gain or loss-of-function cell lines. In addition, we provide access to wide array of computational data analyses. BMGen also offers partnering deals for clients interested in customized integration of several technologies. Core technologies: Lentivirus mediated RNAi and biochip technologies. Categories of activity: Biotech company; Production; R&D; Other service; Biomaterials; |
Biomire Oy
PO Box 135, FI-33721 Tampere, Finland
Founded: 2004 | Pertti Viitanen, Managing Director
Phone: +358 20 778 9500
Fax: +358 3 317 0225
| Production (and other) activities: Biomire plans to start production in 2008. R&D activities: The company develops new innovative drug releasing bioresorbable implants. Categories of activity: Biotech company; R&D; Biomaterials; |
Bioprojects Consulting Services Ltd.
Vähäntorpankuja 7, FI-02180 Espoo
| Lauri Jalkanen, Director
Phone: +358-40-9030084
Fax:
laurijalkanen(at)dlc.fi | Production (and other) activities: Consulting services:
Business development of Life science fields. Assisting new (bio)technology based SMEs in focusing their strategies. Evaluation of new projects. Technology strategies. Market surveys. Business plans. Finding the necessary international business skills. Categories of activity: Other service; |
Bioretec Oy
Hermiankatu 22, Modulight Building, PO Box 135, FI-33721 Tampere, Finland
Web site: www.bioretec.com
Founded: 1998
Personnel: 23 | Risto Penttilä, Managing Director
Phone: +358 20 778 9500
Fax: +358 3 317 0225
risto.penttila(at)bioretec.com | Production (and other) activities: Develops and manufactures new and innovative bioabsorbable devices for various fields of surgery in global markets. R&D activities: Development of novel bioabsorbable, bioactive or drug-releasing devices. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Biosafe - Special Laboratory Services Oy Ltd.
| | Categories of activity: |
Biotech Job Partner Oy Ab
Tykistökatu 4 D, FI-20520 Turku, Finland
Web site: www.biotechjobpartner.com
Founded: 2002
Turnover: EUR 0,1 million
Personnel: 1 | Anders Laurén, Managing Director
Phone: +358 2 410 1735
Fax: +358 2 410 1710
anders.lauren(at)biotechjobpartner.com | Production (and other) activities: Biotech Job Partner is a recruitment company. Our clients are leading biotechnology and pharmaceutical companies. Categories of activity: Biotech support company; Other service; |
BioTie Therapies Oyj
Tykistökatu 6, FI-20520 Turku, Finland
Web site: www.biotie.com
Founded: 1992
Turnover: EUR 1,118 million (2006)
Personnel: 40 (2006) | Kai Lähdesmäki, V.P. Business Development
Phone: +358 2 274 8941
Fax: +358 2 274 8910
kai.lahdesmaki(at)biotie.com Timo Veromaa, President & CEO
Phone: +358 2 2748 901
Fax: +358 2 274 8 910
timo.veromaa(at)biotie.com | Production (and other) activities: BioTie is a product development company developing proprietary pharmaceutical products with extensive IP.
Major partnering agreements have already been signed with global pharmaceutical companies like Roche, H. Lundbeck and other international companies.
R&D activities: BioTie R&D programs are developed from idea to end of Clinical Phase II (PoC).
When PoC is reached, the R&D programs are outlicensed to global and multinational pharmaceutical companies for extensive Clinical Phase III trials and international marketing.
Core technologies: The focus of BioTie R&D covers research and development for creating pharmaceutical products for the treatment of addiction disorders, autoimmune diseases and coagulation disorders. Categories of activity: Biotech company; R&D; Drug discovery; |
Biotop Oy
Tykistökatu 6 B 3, FIN-20520 Turku, Finland
Web site: www.biotop.fi
Founded: 1992
Turnover: EUR < 1 million
Personnel: 3 | Risto Ranta, CEO
Phone: +358 2 241 0099
Fax: +358 2 241 0111
ristor(at)netti.fi | Production (and other) activities: Distribution of biodiagnostic kits and molecularbiology products. R&D activities: Development of novel immunoassay kits. Categories of activity: Biotech company; Production; Diagnostics and devices; |
Biovian Oy
| | Categories of activity: |
Bioxid Ltd
| | Categories of activity: |
Boneca Oy
| | Categories of activity: |
Boreal Plant Breeding Ltd
| | Categories of activity: |
Brion Scientific Ltd
| | Categories of activity: |
Carbozyme Ltd
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.carbozyme.fi
Founded: 1999 | Fred Fenel, Managing Director
Phone:
Fax:
fred.fenel(at)carbozyme.fi | R&D activities: Development and commercialization of products and methods of protein engineering. Categories of activity: Biotech company; R&D; R&D service; Enzymes; |
Cardiocode-Finland Ltd.
| | Categories of activity: |
Cellomeda Oy
BioCity, Tykistökatu 6 A, DIO, FIN-20520 Turku, Finland
Founded: 1991 | Hannu Merikallio, Managing Director
Phone: +358 2 2410104
Fax:
hannu.merikallio(at)cellomeda.com | Production (and other) activities: Production and Applications of clean medical cellulose for medical use. Core technologies: Cellulose sponge for medical use. Categories of activity: Biotech company; R&D; Biomaterials; |
Cel´Amanzi Oy
Web site: www.celamanzi.com
| | Categories of activity: |
Cerebricon Ltd.
Microkatu 1, FIN-70210 Kuopio, Finland
Web site: www.cerebricon.com
Personnel: 24 | Juha Yrjänheikki, CEO
Phone: +358 17 368 0801
Fax: +358 17 368 0803
juha.yrjanheikki(at)cerebricon.com Patrick Sweeney, Director of Business Development
Phone: +358 17 368 0801
Fax: +368 17 368 0803
patrick.sweeney(at)cerebricon.com | Production (and other) activities: Independent contract based research company providing specialized in vitro and in vivo brain disease models for testing and developing new pharmaceutical compounds for stroke, Alzheimer´s, Parkinson, Huntington, trauma, migraine etc. R&D activities: Development of models that are crucial for studying the efficiency of drugs, resolving the mechanisms action, searching new drug candidates for brain diseases, and screening for new drug targets. Fee-based services or shared R&D projects possible. Core technologies: Validated disease models with analysis methods ranging from molecular to functional and behavioral tests. Categories of activity: Biotech company; R&D; Drug discovery; |
Chip-Man Technologies Ltd
Biokatu 10, FI-33520 Tampere, Finland
Web site: www.chipmantech.com
Founded: 2002
Personnel: 4 (2004) | Korpinen Juha, CEO
Phone: +358 3 3138 7046
Fax:
juha.korpinen(at)chipmantech.com | Production (and other) activities: Chip-Man Technologies produces living cell analysis systems, which don't need any labeling or markers, also the company produces cell-based-assays which are used in these systems. R&D activities: Machine Vision, machine learning, biology, cell models, cell based assays. Core technologies: Machine Vision, machine learning, biology, cell models, cell based assays. Categories of activity: Biotech support company; R&D service; Drug discovery; |
City-Lab Oy
Tykistökatu 6 floor 1, FI-20520 Turku, Finland
Web site: www.city-lab.fi
Founded: 1993
Personnel: 5 (2005) | Päivi Kemppainen
Phone: +358 2 469 1057
Fax: +358 2 469 1058
paivi.kemppainen(at)city-lab.fi | Production (and other) activities: We have three bioshops, one in Biocity, Turku and two others in Biomedicum and in Viikki, in Helsinki. In our shops you can shop or order reagents, consumables and small instruments from the companies we work with. Categories of activity: Biotech support company; Other service; Supplier; |
Clinical Research Services Turku CRST
Itäinen Pitkäkatu 4 B, FIN-20520 Turku, Finland
Web site: www.crst.utu.fi
Founded: 1995
Turnover: EUR 1 million
Personnel: 16 (2004) | Anssi Himmanen
Phone: +358 2 333 7635
Fax: +358 2 333 7216
anssi.himmanen(at)utu.fi Mika Scheinin
Phone: +358 2 333 7502
Fax: +358 2 333 7216
mika.sheinin(at)utu.fi | Production (and other) activities: - Phase I and phase II clinical studies - Clinical studies of medical devices, nutraceuticals and functional foods - Study design and protocol writing - Clinical Study reports Categories of activity: Biotech support company; R&D service; Other service; Drug discovery; Biomaterials; Food and feed; |
CNServices Oy
| | Categories of activity: |
ConMed Linvatec Biomaterials Oy
PO Box 3, FI-33721 Tampere, Finland
Web site: www.linvatec.com
Founded: 1984
Personnel: 60 (2005) | Kaj Koskinen, Managing Director
Phone: +358 3 316 5600
Fax: +358 3 316 5688
infofinland(at)linvatec.com | Production (and other) activities: ConMed Linvatec Biomaterials is the leading developer and manufacturer of procedure specific medicine products. R&D activities: Research and development of bioabsorbable surgical implants and instrumentation for procedure specific applications. R&D is based on high expertise and long experience of biomaterials and on comprehensively patent protected technologies. Core technologies: ConMed Linvatec Biomaterial's products are based on innovative material advantage, combined with worldwide patents and state of the art technologies. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Convergent Solutions International CSI
| | Categories of activity: |
CRS Biotech Oy
Torikatu 8, FI-39200 Kyröskoski, Finland
Web site: www.crsbiotech.fi
Founded: 1995
Turnover: EUR 0,6 million (2007)
Personnel: 6 (2007) | Jari Siivari, Dr., Managing Director
Phone: +358400892386
Fax: +35833714330
jari.siivari(at)crsbiotech.fi | Production (and other) activities: Plant extracts for nutraceutical and cosmetic industry R&D activities: Agrobiotechnology, rural development projects including natural raw materials Core technologies: Dry extract production, vacuum drying, laboratory methods for biological samples (flavonoids, streols vitamins, etc.) Categories of activity: Biotech company; Production; R&D; Biomaterials; Food and feed; Agro; |
CSI Biotech Ltd
Tapionkatu 4 B, FIN-40100 Jyväskylä, Finland
Web site: www.csibiotech.com
Founded: 2000
Personnel: 3 | Ms Vuokko Jansson, Research DirectoManaging Director
Phone: +358 14 272 788 and
Fax: +358 14 272 234
vuokko.jansson(at)csibiotech.com Dr Kristian Jansson, Research Director
Phone: +358 14 272 788, +35
Fax: +358 14 272 234
kristian.jansson(at)csibiotech.com | R&D activities: Invents and develops innovative technologies for diagnostics and life science research. Core technologies: SNP analysis, DNA sequencing, DNA amplification. Categories of activity: Biotech company; R&D; Other service; Diagnostics and devices; |
Culminatum Ltd. Oy - Helsinki Region Centre of expertise
Innopoli, Tekniikantie 12, 02150 Espoo
Web site: www.culminatum.fi
Founded: 1995
Personnel: 2 (2007) | Riikka Paasikivi, Program Director
Phone: +358-50-5215944
Fax: +358-10 2178901
riikka.paasikivi(at)culminatum.fi Susanna Jaarmo, Project Coordinator
Phone: +358-50-5346047
Fax: +358-10 2178901
susanna.jaarmo(at)culminatum.fi | Production (and other) activities: Culminatum Ltd Oy is a development company owned by the Uusimaa Regional Council, the cities of Helsinki, Espoo and Vantaa, and the universities, polytechnics, research institutes and business community of Helsinki region.
The main function of Culminatum Ltd Oy is to manage the Centre of Expertise Programme within Helsinki Region over the current third programme period 2007 - 2013. This programme promotes utilisation of the highest international standard of knowledge and expertise in business, job creation and regional development.
R&D activities: Over the years 2007-2013 the Centre of Expertise programme covers nine cluster fields in the Helsinki region:
> Digital Content Business
> Environmental Technology cluster
> Food Processing Development cluster
> HealthBio - Health cluster
> Living cluster
> Nano and Micro Systems and Future Materials, www.fmnt.net
> Tourism and Experience Industry
> Ubiquitous Computing
> Well-being cluster
Categories of activity: Other service; |
CyFlo Ltd
Itäinen Pitkäkatu 4 B, 20520 Turku, Finland
Web site: www.cyflo.fi
| Jussi Vaahtovuo, CEO
Phone: +358-2-4788520
Fax: +358-2-4788521
jussi.vaahtovuo(at)cyflo.fi | Production (and other) activities: CyFlo offers microbiological and immunological research and development services for food and feed industry, life sciences sector and other industries interested in microbes. Categories of activity: Biotech company; Biotech support company; R&D; R&D service; Other service; Diagnostics and devices; Food and feed; |
Danisco Technology Center
Sokeritehtaantie 20, FIN-02460 Kantvik, Finland
Web site: www.danisco.com
Personnel: 97 | Nina Rautonen, Director, Bioscience
Phone: +358 9 297 4512
Fax: +358 9 298 2203
nina.rautonen(at)danisco.com Pekka Piiroinen, Development Director
Phone: +358 9 297 4500
Fax: +358 9 298 2203
pekka.piiroinen(at)danisco.com | Production (and other) activities: Production Food and feed ingredients, sweeteners and speciality carbohydrates. R&D activities: Gut microbiology and physiology and immunology, nutrition, gene technology, enzymology, fermentation, separation and process technology. Core technologies: Gene Technology, Separation Technology. Categories of activity: Biotech company; R&D; Agro; Enzymes; |
DelSiTech Ltd
Itäinen Pitkäkatu 4 D, FI-20520 Turku, Finland
Web site: www.delsitech.com
Founded: 2001 | Harry Jalonen, CEO
Phone: +358 2 4788 640
Fax: +358 2 4788 120
harry.jalonen(at)delsitech.com Gunnar Björkstén, Vice President Business Development
Phone: +358 2 4788 640
Fax: +358 2 4788 120
gunnar.bjorksten(at)delsitech.com | Production (and other) activities: DelSiTech Ltd specialises in a silica-based implant, subcutaneous and intra-muscular injectable technology for controlled release of small molecular drugs and biopharmaceuticals: proteins, polysaccharides (heparin) and viruses. Core technologies: DelSiTech(TM) is an advanced therapeutics delivery technology for implants, subcutaneous and intramuscular administration suitable for the controlled delivery of a wide range of active ingredients, including small molecules, proteins, heparin and viruses. The proprietary technology is based on silica (SiO2) matrix into which the active ingredient is embedded. The matrix can be designed to degrade at the required rate to assure a tightly controlled release of the active substance, providing a better therapeutic effect in situ and causing lower systemic toxicological side-effects than alternative delivery systems. The proof of principle has been demonstrated in animal testing both with small synthetic drugs and biologics like viruses. The technology was developed in two universities by the Biomaterial Research Group in Turku, Finland and is owned and patented by DelSiTech Ltd. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Dermagene Oy
Biokatu 10, FI-33520 Tampere, Finland
Web site: www.dermagene.net
Founded: 2005
Personnel: 7 (2007) | Marja Tähtinen, COO
Phone: +358-50-567 8388
Fax: +358-3-2552 153
marja.tahtinen(at)dermagene.com | Production (and other) activities: NAV3 gene deletion test-kit for cancer diagnostics.
NAV3 gene deletion assay (biomarker) services for pharmaceutical companies having investigational new drugs in Phage I/II clinical trials. R&D activities: Dermagene Oy is a biotech company focusing on the development of cancer diagnostic test for cutaneous T-cell lymphoma (CTCL) and certain carcinomas. The tests, which are based on fluorescent in situ hybridization (FISH), are screening for NAV3 gene deletion, recently described to be present already at the early phase of various cancers. Categories of activity: Biotech company; R&D; R&D service; Diagnostics and devices; |
Elinkeinoyhtymä Antopolsky Maxim ja Mikhailov
| | Categories of activity: |
Elisante Ky
| | Categories of activity: |
Elomatic Oy
Itäinen Rantakatu 72, FI-20810 Turku, Finland
Web site: www.elomatic.com
Founded: 1970
Turnover: EUR 38 million (2006)
Personnel: 600 (2006) | Aulis Rajala, Vice President
Phone: +358 2 412 4311
Fax: +358 2 412 4444
aulis.rajala(at)elomatic.com | R&D activities: Process development, Document management program, 3D-CAD solutions, CADMATIC. Core technologies: Consulting and engineering services from feasibility studies to validation and plant start-up for pharmaceutical and biotech investment projects. 3D-design using CADMATIC and CADMATIC eBrowser, Automation systems, Clean room design and Validation services. Categories of activity: Biotech support company; R&D service; |
Encorium Oy/Ltd.
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.encorium.com
Founded: 1996
Turnover: EUR 10 million
Personnel: 106 (2004) | Dr Kai Lindevall, CEO
Phone: +358 20 751 82 00
Fax: +358 20 751 8250
klindevall(at)encorium.com Hanna Kanerva, Senior Director, Country Manager
Phone: +358 20 751 8200
Fax: +358 20 751 8250
hkanerva(at)encorium.com | Production (and other) activities: Encorium is a Clinical Research Organisation (CRO) providing clinical research services to pharmaceutical, food and biotech companies. Encorium is a full service global CRO. Our areas of expertise are Cardiology and Cardiovascular diseases, Oncology, Immunology and Vaccines, CNS, and Endocrinology. Categories of activity: Biotech support company; Other service; |
EvoStem Finland Ltd.
Suntinmäentie 30, FI-36200 Kangasala, Finland
Founded: 2006 | Minna Leppänen, Managing Direcor
Phone: +358-40-504 4423
Fax:
minna.leppanen(at)evostem.com | Production (and other) activities: EvoStem develops, produces and markets stem cell therapies for veterinary use. Categories of activity: Biotech company; Production; R&D; |
Faron Pharmaceuticals Oy Ltd
Itäinen Pitkäkatu 4 B, FI-20520 Turku, Finland
Web site: www.faronpharmaceuticals.com
Founded: 2002
Turnover: EUR 0.16 million (2004)
Personnel: 1 (2004) | Markku Jalkanen, CEO
Phone: +358 40 520 6124
Fax: +358 2 478 8411
markku.jalkanen(at)faronpharmaceuticals.com | Production (and other) activities: Drug discovery and drug development services. R&D activities: Inflammation, Cancer, Traumas, Functional foods. Core technologies: Cell trafficking and adhesion (Clever, CD73, Vap-1, CD44v6), Biologically active GAGs, Farbetics, Tumobiotics. Categories of activity: Biotech company; Biotech support company; R&D; Other service; Drug discovery; Food and feed; |
FBD Oy Ltd
Lemminkäisenkatu 14-18 A U, FIN-20520 Turku, Finland
Web site: www.fatmanbiodesigns.com
Founded: 1999 | Prof. Mark S. Johnson, CEO
Phone: +358 40 505 9343
Fax: +358 2 215 3280
mark.johnson(at)fatmanbiodesigns.com | Production (and other) activities: FBD specializes in the computer-aided design of small molecule ligands on the basis of protein structural information and using bioinformational methods. Proprietary software is under development to help streamline the ligand design process. Core technologies: Protein modelling, x-ray crystallography, ligand design. Categories of activity: Biotech company; R&D service; Bioinformatics; |
Fennopharma Oy
| | Categories of activity: |
Fermlab Oy
Lemminkäisenkatu 30, FI-20520, Turku, Finland
Web site: www.fermlabs.com
Founded: 2000
Personnel: 2 | Ari Båtsman, Managing Director
Phone: +358 2 2410012
Fax: +358 50 5731828
ari.batsman(at)fermlab.fi | Production (and other) activities: Manufacturing, sales and marketing of research reagents and probiotic bacteria. Subcontract manufacturing and services to diagnostic, biopharma and food industry and related research institutes. R&D activities: Research and development of probiotic bacteria applications. Core technologies: Research reagents: purification of CNS based proteins.
Probiotic bacteria: Functional effects, stability and other properties. Process optimization. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Enzymes; Research reagents; |
Fibrogen Europe Oy
Tukholmankatu 8 B Biomedicum II, FI-00290 Helsinki, Finland
Web site: www.fibrogeneurope.com
Founded: 1995
Personnel: 3 | Dr Juha Koivurinta
Phone: +358 9 563 73 221
Fax: +358 9 563 73 224
jkoivurinta(at)fibrogeneurope.com | Production (and other) activities: Pilot production of different collagen types. R&D activities: Development of different collagen types, mainly types I, II, III and different collagen fragments (gelatins) for pharmaceutical and medical device use. Core technologies: Production of stable recombinant human collagens and gelatin using the patented multi-gene technology. Categories of activity: Biotech company; Supplier; Biomaterials; |
FinFlax Oy Ltd
Pekantie 21, FI-90900 Kiiminki, Finland
Founded: 1991
Personnel: 3 | Mr Pekka Vilppunen, Managing Director
Phone: +358 400 686 089
Fax: +358 8 816 2445
info(at)finflax.com | R&D activities: New biotechnical refining process for production of flax fibre used in textile industry and for composite materials. Categories of activity: Biotech company; R&D; Agro; |
Finn-Medi Research Ltd
Finn-Medi Science and Business Park
Biokatu 12, FI-33529 Tampere, Finland
Web site: www.finnmediresearch.com
Founded: 1995
Turnover: EUR 2 million
Personnel: 14 | Matti Eskola, Managing Director
Phone: +358 3 3116 4020
Fax: +358 3 3116 4029
matti.eskola(at)finnmedi.fi Tiina Kärjä-Lahdensuu, Research Manager
Phone: + 358 3 3116 4034
Fax: + 358 3 3116 4029
tiina.karja-lahdensuu(at)finnmedi.fi | Production (and other) activities: Finn-Medi Research offers expertise and services for health and biotechnology companies, researchers and pharmaceutical industry. Customers represent from biotechnology start-ups up to major pharmaceutical companies. Services include clinical trials (phase I-IV), business development and licensing, R&D consulting and project management. Finn-Medi Research also coordinates biotechnology development programs such as BioneXt Tampere and Centre of expertise programme. Bionext Tampere is 100 milion investment and development programme that focuses on immunology and vaccines, biomaterials and tissue technology and applied information technologies. Categories of activity: Biotech support company; Biotech centre; R&D service; Other service; |
Finnfeeds Finland Ltd (trading as Danisco Animal Nutrition)
Sokeritehtaantie 20, FIN-02460 Kantvik, Finland
Web site: animalnutrition.danisco.com
Founded: 1998
Turnover: EUR 35 million
Personnel: 80 | Juhani O. Kuusisto, Managing Director
Phone: +358 10 4314686
Fax: +358 10 4314333
juhani.kuusisto(at)danisco.com | Production (and other) activities: Production Production facility in Naantali producing betaine and other molasses based fine chemicals. Core technologies: Cromatographic separation. Categories of activity: Biotech company; Production; Food and feed; Enzymes; |
Finnfeeds Ltd (trading as Danisco Animal Nutrition)
PO Box 461, FIN-65101 Vaasa, Finland
Web site: animalnutrition.danisco.com
Founded: 1991
Turnover: EUR 35 million
Personnel: 16 | Juhani O. Kuusisto, Managing Director
Phone: +358 10 4314686
Fax: +358 10 4314333
juhani.kuusisto(at)danisco.com Rainer Skinnar, Plant Manager
Phone: +358 10 4313508
Fax: +358 10 4313500
rainer.skinnar(at)danisco.com | Production (and other) activities: Production Production facility in Vaasa producing feed enzymes. Categories of activity: Biotech company; Production; Food and feed; Enzymes; |
Finnish Red Cross Blood Service
Kivihaantie 7, FIN-00310 Helsinki, Finland
Web site: www.veripalvelu.fi
Founded: 1947
Turnover: EUR 70 million (2005)
Personnel: 500 (2005) | Jukka Partanen, Research Director
Phone: +358 9 5801298
Fax: +358 9 5801429
jukka.partanen(at)veripalvelu.fi | Production (and other) activities: Blood and blood-related products; laboratory service for organ and stem cell transplantation; laboratory services related to haemostasis, coagulation and blood grouping. R&D activities: Stem cells; tissue banking; services for organ and stem cell transplantation. Core technologies: In R&D: Cell and molecular biology; genomics and genetics; Categories of activity: Biotech company; R&D; Other service; |
Finnoflag Oy
PO Box 262, FIN-70110 Kuopio, Finland
Web site: www.finnoflag.com
Founded: 1993 | Elias Hakalehto, PhD
Phone: +358 500 574 289
Fax: +358 17 282 2838
finnoflag(at)co.inet.fi | Production (and other) activities: Production Microbe samplers and sample treatment devices, reagents, services. R&D activities: Tests for rapid microbe diagnostics, new innovative tools for microbiology. Core technologies: New microbe detection and sampling technologies, development of health promoting substances. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Finnzymes Oy
Keilaranta 16 A, FI-02150 Espoo, Finland
Web site: www.finnzymes.com
Founded: 1986
Personnel: 60 (2005) | Pekka Mattila, CEO
Phone: +358 9 584 121
Fax: +358 9 5841 2200
fz(at)finnzymes.fi | Production (and other) activities: Thermostable DNA polymerases, other enzymes for molecular biology, transposon-based systems for sequencing and protein functional analysis, PCR-based animal diagnostics. Core technologies: PCR, sequencing. Categories of activity: Biotech company; Production; R&D; Supplier; Diagnostics and devices; Enzymes; |
FIT Biotech Oyj Plc
Biokatu 8, FI-33520 Tampere, Finland
Web site: www.fitbiotech.com
Founded: 1995
Personnel: 40 (2004) | Kalevi Reijonen, CEO & President
Phone: +358 33138 7000
Fax: +358 3 3138 7050
kalevi.reijonen(at)fitbiotech.com | Production (and other) activities: FIT Biotech Plc is an innovative medical biotechnology company engaged in the development and commercialization of its proprietary Gene Transport Unit (GTU®) technology and GTU product applications in DNA vaccination and immune therapy. The company's other areas of expertise are artificial immunogen, recombinant protein and antibody technologies, as well as GMP grade process development and production of DNA vaccines. In addition, the company has developed and launched test kits for the detection of natural latex allergens. FIT Biotech was established in 1995 and is located in Tampere, Finland, with operations also in Tartu, Estonia. R&D activities: Leveraging its GTU technology platform, FIT Biotech has built a strong product pipeline that comprises a therapeutic HIV vaccine, a preventive HIV vaccine, as well as vaccines for melanoma, diabetes and hepatitis C. FIT Biotech's HIV vaccine programs have already progressed to the Phase I/II stage. Core technologies: GTU technology: applicable to DNA vaccination as well as to immuno and gene therapies for the modulation of the immune system via antigens or cytokines for use in the treatment of infectious diseases, cancer and allergies. Categories of activity: Biotech company; Production; R&D; R&D service; Supplier; Drug discovery; Diagnostics and devices; |
Fluilogic Oy
Westendintie 1, FIN-02160 Espoo, Finland
Web site: www.fluilogic.fi
Founded: 1978
Personnel: 1 | Ilkka Talvinen
Phone: +358 40 555 0294
Fax: +358 9 43923021
ilkka.talvinen(at)fluilogic.fi | Production (and other) activities: Production sale and markeitng of EMB-dispenser modules and sales of the Viaflo sample processor R&D activities: Development of dispenser systems for dispense range of 50 nanoliters to 1000 microliters. Core technologies: EMB-technology, a Fluilogic patented dispenser technology. Categories of activity: Biotech support company; Production; R&D; Diagnostics and devices; |
Foodfiles Oy Ltd
Neulaniementie 2 L 6, FI-70210 Kuopio, Finland
Web site: www.foodfiles.com
Founded: 1998
Personnel: 10 (2004) | Dr Essi Sarkkinen, Managing and Research Director
Phone: +358 17 288 1261 and
Fax: +358 17 288 1269
essi.sarkkinen(at)foodfiles.com Ms Pirjo-Leena Kinanen-Nimmrichter, Administrative Manager
Phone: +358 17 288 1270 and
Fax: +358 17 288 1269
pirjo-leena.kinanen-nimmrichter(at)foodfiles.com | R&D activities: Clinical studies for food and pharmaceutical industry, regulatory affairs (food, food ingredients) for food industry, consultation in nutrition and health claims. Categories of activity: Biotech support company; R&D service; Food and feed; |
Foodsteps Oy
Viikinkaari 6, FI-00790 Helsinki, Finland
Web site: www.foodsteps.fi
Founded: 2003
Personnel: 1 | Jukka Jämsä, Consultant
Phone: 0400 811503
Fax:
jukka.jamsa(at)foodsteps.fi | Production (and other) activities: Foodsteps Ltd. is consulting b.to b.sales and export activities of food- ,healthfood- and feed ingredients. We work in a network of several consultants - all specialists in making the agricultural products to valuable ingredients for global industry. We can find the commercial value of an invention in this sector, and also make the first steps to commercialize it. R&D activities: Market researches in Russia (Food, feed and pharma industry, and consumer researches). In Scandinavia we are specialized into market of industrial food ingredients. Categories of activity: Biotech support company; R&D service; Other service; Supplier; Biomaterials; Food and feed; Agro; Environment; Enzymes; |
FRH Technology Partnership Oy Ltd
Neitsytpolku 2b A 15-16, FIN-00140 Helsinki, Finland
Founded: 2003
Personnel: 3 | Kai Falck
Phone: +358 50 5233 683
Fax: +358 9 638 724
kai.falck(at)welho.com Päivi Ryöppy
Phone: +358 50 536 5233
Fax: +358 9 638 724
paivi.ryoppy(at)welho.com | Production (and other) activities: Management consulting, creating international partnerships, business development services, analysis and studies on life science sector. Categories of activity: Biotech support company; Other service; |
Galanthia
Web site: www.galanthia.com/index.html
| | Categories of activity: |
Galilaeus Oy
Kairiskulmantie 10, PO Box 113, FI-20781 Kaarina, Finland
Web site: www.galilaeus.fi
Founded: 1994
Personnel: 27 (2005) | Kristiina Ylihonko, CEO
Phone: +358 2 274 1450
Fax: +358 2 273 1460
kristiina.ylihonko(at)galilaeus.fi | Production (and other) activities: Contract manufacturing of New Chemical Entities (NCE's) and small volume intermediates or on-market active ingredients. Galilaeus has GMP compliant fermentation facility for the manufacture of small molecule pharmaceuticals, also cytostatics.
Process development for small molecule fermentation including strain construction/improvement, optimisation of fermentation conditions, downstream development, scale-up. R&D activities: Development of highly efficient fermentation processes for technologically demanding active pharmacetical ingredients and NCE's. Core technologies: Control of biosynthetic pathways in microbes by genetic engineering. Natural products chemistry. Categories of activity: Biotech company; Biotech support company; Production; R&D; |
Genencor International Oy
PO Box 13, FIN-42301 Jämsänkoski, Finland
Web site: www.genencor.com
Founded: 1990
Turnover: EUR 62 million
Personnel: 200 | Jouni Viljanen
Phone: +358 14 7494 400
Fax: +358 14 7494 410
jviljanen(at)genencor.com Aino Mansikkamäki
Phone: +358 19 2804 300
Fax: +358 19 2804 307
amansikkamaki(at)genencor.com | Production (and other) activities: Production Industrial enzymes and industrial fermentations. Core technologies: Manufacturing of industrial enzymes. Categories of activity: Biotech company; Production; Enzymes; |
Genolyze Ltd
PO Box 140, FIN-20521 Turku, Finland
Web site: www.genolyze.com
Founded: 2003
Personnel: 7 | Marko Mäenpää, CEO
Phone: +358 50 4616530
Fax: +358 10 633 8189
marko.maenpaa(at)genolyze.com | Production (and other) activities: Genolyze is bioinformatics research Service Company specializes in enhancing research, development and production processes by applying Bio-IT know-how.
Company’s mission is to save researchers time and grow the value of measured data by revealing the useful information hidden into the massive data and complex multivariable studies.
R&D activities: Computational methods for biological data, Biomarkers, Biological data management Core technologies: Sophisticated data analysis and computational methods, Mathematical and statistical modelling, Data management, IT and Bio-database systems. Categories of activity: Biotech company; Biotech support company; R&D service; Other service; Bioinformatics; |
GenoSyst Ltd.
Itäinen Pitkäkatu 4B, FI-20520 Turku, Finland
Web site: www.genosyst.com
Founded: 2006
Personnel: 7 (2007) | Robert Hermann, CEO
Phone: +358 2 478 8360
Fax: + 358 2 478 8120
robert.hermann(at)genosyst.com Attila Gyenesei, Director of Research and Development
Phone: +358 2 478 8360
Fax: + 358 2 478 8120
attila.gyenesei(at)genosyst.com | Production (and other) activities: GenoSyst Ltd. offers software and data analysis services for various domains of biosciences and bioindustry, with special focus on systems biology applications: transcriptomics - global gene expression profiling, genomics - disease gene mapping, proteomics and metabolomics. Additionally we provide in silico tools for drug discovery. R&D activities: GenoSyst Ltd. carries out research and development in the following areas: novel data mining techniques for whole genome association scans, whole genome sequence patterns discovery, global expression profiling, in silico HTS drug discovery - QSAR, maximal common substructures. Core technologies: Applications of advanced mathematics to uncover hidden knowledge in large scale biological datasets, advanced statistics, data mining. Categories of activity: Biotech company; Production; R&D; Other service; Bioinformatics; |
Genxpres Ltd
| | Categories of activity: |
Glomega Inc Oy
Messeniuksenkatu 6 A 18, FIN-00290 Helsinki, Finland
Web site: www.glomega.com
Founded: 1999
Personnel: < 5 | Riitta Holthöfer, CEO
Phone: +358 40 738 6262
Fax:
riitta.holthofer(at)helsinki.fi | R&D activities: R&D activities : MoAbs, Development of novel diagnostic assays, novel analytes. Core technologies: Core technologies : Molecular basis and lead molecules of diabetic nephropathy and other metabolic diseases. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Glykos Finland Oy
| | Categories of activity: |
H. Lundbeck Oy Ab
| | Categories of activity: |
HaartBio Oy Ab
Haartmaninkatu 3, FI-00290 Helsinki, Finland
Web site: www.haartbio.fi
Founded: 2003 | Tiina Rissanen, Managing Director
Phone: +358 9 4369 3004
Fax: +358 9 4369 3006
tiina.rissanen(at)haartbio.fi | Production (and other) activities: Operates between university and biotechnological and medical companies marketing academic know-how and products. Categories of activity: Biotech support company; Other service; |
Headman Ltd
Porttitie 11 D, FIN-02180 Espoo, Finland
Web site: www.headman.fi
Founded: 1992
Personnel: < 10 | Klaus Hedman, MD, Professor
Phone: +358 50 5249 086
Fax:
klaus.hedman(at)helsinki.fi | Production (and other) activities: Diagnostics for infectious diseases. R&D activities: Diagnostics for infectious diseases; outsourced R&D; diagnostic consultation. Core technologies: IgG-avidity and epitope-type specificity serodiagnostics; other innovative antibody-EIA techniques; recombinant protein expression; molecular biology; quantitative PCR. Categories of activity: Biotech company; R&D; Diagnostics and devices; |
Helsinki Business and Science Park Ltd
Viikinkaari 4, FI-00790 Helsinki, Finland
Web site: www.hbsp.net
Founded: 1992
Turnover: EUR 2,8 million
Personnel: 15 (2006) | Pia Ylhä, CEO
Phone: +358 9 319 36 540
Fax: +358 9 319 36 554
pia.ylha(at)hbsp.net | Production (and other) activities: Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within food technology, biotechnology, drug development and diagnostics, as well as environmental technology. HBSP operates in two campuses within the City of Helsinki, in Viikki Biocampus and in Meilahti Medical Campus. Categories of activity: Biotech centre; Other service; |
Hidex Oy
| | Categories of activity: |
Histola Research Oy
Niittyhaankatu 20, FI-33720 Tampere
Web site: www.histola.com
Founded: 2004
Personnel: 10 (2008) | Pia Kivijärvi, Managing Director
Phone: +358 20 7432 007
Fax: +358 20 7432 001
pia.kivijarvi(at)histola.fi Katja Veneskoski, Laboratory Manager
Phone: +358 20 7432 002
Fax: +358 20 7432 001
katja.vaneskoski(at)histola.fi | Production (and other) activities: Histola Research Ltd is a contract research organization that offers testing and tailored experts services for non-clinical operations. Histola is having GLP accredited laboratory premises. Our services covers from research planning to practical arrangements and project management. We are committed to long term high quality co-operation and cost-efficient expertise in the implementation of non-clinical operations.
• IN VITRO TOXICOLOGY AND CELL BIOLOGICAL RESEARCH
• HISTOTECHNOLOGY (Immunohistochemistry)
• ENVIRONMENTAL RESEARCH, ECOTOXICITY TESTING AND CONSULTANCY
• NANOSAFETY
• CHEMICAL TESTING (REACH) AND CONSULTANCY
• PROJECT MANAGEMENT SERVICES AND CONSULTANCY
Categories of activity: Biotech support company; R&D; R&D service; Other service; Supplier; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Environment; |
Hormos Medical Corp. - a subsidiary of QuatRx Pharmaceuticals Company
USA
Itäinen Pitkäkatu 4, FIN-20520 Turku, Finland
Web site: www.hormos-med.com
Founded: 1997
Turnover: EUR 2 million (2004)
Personnel: 38 (2004) | Dr Risto Lammintausta, CEO
Phone: +358 2 410 8000
Fax: +358 2 410 8001
risto.lammintausta(at)hormos-med.com | Production (and other) activities: QuatRx Pharmaceuticals Company, a biopharmaceutical company, focuses on research and development of therapeutic compounds primarily for the treatment of major endocrine, metabolic and cardiovascular diseases, especially dyslipidemia and endocrine diseases of aging. QuatRx has its headquarters in Ann Arbor, Michigan, with a significant presence in Europe through Hormos Medical Corp., a wholly-owned subsidiary of QuatRx Pharmaceuticals Company. R&D activities: The research activities of the company are based on its expertise in tissue-specific steroid hormone effects at the molecular and cellular level. Currently running projects in the indication areas of menopausal symptoms, androgen deficiency disorders, dyslipidemia. Core technologies: The company's core technologies include selective estrogen receptor modulators (SERM), selective androgen receptor modulators (SARM) and hydroxysteroid dehydrogenase (HSD) inhibitors. Categories of activity: Biotech company; R&D; Drug discovery; |
Hycail Finland Oy
Itäinen Pitkäkatu 4B (Pharmacity 4th floor), FI-20520 Turku, Finland
Web site: www.hycail.com
Founded: 2004
Personnel: 3 (2004) | Svante Wahlbeck, Managing director
Phone: +358 400 828 326
Fax: +358 2 478 8581
wahlbeck(at)hycail.com | Production (and other) activities: Production of renewable and bio-degradable materials from lactic acid (PLA). R&D activities: Development of new materials and applications based on lactic acid polymers (PLA) or co-polymers. Core technologies: Polylactic acid (PLA). Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Hytest Ltd.
PharmaCity, Itäinen Pitkäkatu 4C, FI-20520 Turku, Finland
Web site: www.hytest.fi
Founded: 1994
Turnover: EUR 3,2 million (2003)
Personnel: 24 (2003) | Jukka Lehikoinen
Phone: +358 2 512 0900
Fax: +358 2 512 0909
jukka.lehikoinen(at)hytest.fi Susanna Brink
Phone: +358 2 512 0900
Fax: +358 2 512 0909
susanna.brink(at)hytest.fi | R&D activities: HyTest is continuously working to bring new products to the market as well as improving the existing ones through R&D. Our R&D specialists maintain close ties with the scientific community and engage in joint research with the Finnish academic diagnostic research organizations. Core technologies: HyTest has become a leading supplier of several reagents worldwide (such as antibodies and antigens of the troponin complex or native human thyroid peroxidase), at the same time maintaining a broad range of other products. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Imanext Oy/Ltd.
Aleksanterinkatu 17, FI-00100 Helsinki, Finland
Web site: www.imanext.com
Founded: 2006 | Kim Bergström, CEO
Phone: +358 40 415 5741
Fax: +358 10 296 0313
kim.bergstrom(at)imanext.com | Production (and other) activities: Imanext Ltd. provides design and execution of nonclinical and clinical applications for drug development purposes to the pharmaceutical and biotechnology industry. Imanext is a niche CRO (Contract Research Organization), and is operating in the field of functional imaging. Imanext’s services include nonclinical proof-of-concept studies using a wide spectrum of SPECT/PET (Single Photon Emission Computed Tomography / Positron Emission Tomography) tracers, and clinical phase I/II SPECT (including phase 0 and microdosing) studies. Imanext operates with its partners globally. Categories of activity: Biotech support company; Other service; |
Immuno Diagnostic Oy
Kaivokatu 16, FI-13100 Hämeenlinna, Finland
Web site: www.immunodiagnostic.fi
Founded: 1983
Turnover: EUR 3,5 million (2005)
Personnel: 10 (2006) | Dr Marko Laine, Vice President, Sales
Phone: +358 3 6153 725
Fax: +358 3 6822 039
marko.laine(at)immunodiagnostic.fi Mr Jarmo Laakkonen, Vice President, Marketing
Phone: +358 3 6153 726
Fax: +358 3 6822 039
jarmo.laakkonen(at)immunodiagnostic.fi | Production (and other) activities: Production of kits for ultra-rapid immunohistochemical staining on frozen sections. Distribution of reagents, chemicals and instruments for research and diagnostic applications.ISO9001:2000 certificate. R&D activities: Technology transfer, commercialization and consulting. Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Agro; Environment; Enzymes; Research reagents; |
Inion Oy
Lääkärinkatu 2, FI-33520 Tampere, Finland
Web site: www.inion.com
Founded: 1999
Personnel: 95 (2004) | Chris Lee, CEO
Phone: +44 (0) 1483 685 390
Fax:
chris.lee(at)inion.com Julien Cotta, CFO
Phone: +44 (0) 1483 685 390
Fax:
julien.cotta(at)inion.com | Production (and other) activities: Inion is dedicated to developing and manufacturing novel medical devises based on innovative biomaterials. Inion developed solutions feature a range of proprietary technologies and processes that offer significant benefits over alternative methods and have won a growing number of the customers around the world. Priority is given to solutions that can be used quickly and easily, save valuable OR time and are priced competitively. Inion's product range includes biodegradable products for the following surgical applications: Craniomaxillofacial (Inion CPS), Orthopaedics (Inion OTPS), Sports medicine (Hexalon, Trinion) and dental (Inion GTR membrane). R&D activities: Inion's material and product testing is carried out at the company's special R&D laboratory at the headquarters, equipped with state-of-the-art manufacturing, laboratory and office facilities as well as class 10 000 clean room. Materials analysis work is also carried here, and at the reasearch centres and universities around the world. Core technologies: Polymer science and processing technology are the core technologies of Inion. Categories of activity: Biotech company; Production; R&D; Biomaterials; |
Innomedica Oy
Tykistökatu 6 B (BioCity), FI-20520 Turku, Finland
Helsinki office: Tukholmankatu 8 B FIN-00290 Helsinki, Finland
Web site: www.innomedica.fi
Founded: 1997 | Michael T Jones
Phone: +358 2 2748 400
Fax: +358 2 2748 420
innomedica(at)innomedica.fi Tanja Dowe
Phone: Phone +358 9 563 732
Fax: Fax +358 9 563 73209
innomedica(at)innomedica.fi | Production (and other) activities: Innomedica is a service provider for the Life Science industry. Our main service products are: Japan Partnering, Project Management Services, Business Development, Internationalisation. Using our experienced team of Life Science Professionals, we can help our clients to get the best our of their technologies and product ideas. Innomedica is your Partner in Life Sciences. Categories of activity: Biotech support company; Other service; |
Innotrac Diagnostics Oy
Biolinja 12, FI-20720 Turku, Finland
Web site: www.innotrac.fi
Founded: 1995
Personnel: 45 | Hannamaija Fontell, Marketing Director
Phone: +358 2 278 4000
Fax: +358 2 278 4001
| Production (and other) activities: Production and marketing of the Innotrac Aio!TM Immunoassay systems and reagents for cardiac and critical care testing in emergency environments. Contract manufacturing services in streptavidin coated plate and diagnostic reagent production for diagnostics, pharmaceutical companies and research institutions. R&D activities: Development of rapid, quantitative immunoassay systems and reagents for point-of-care and central laboratory testing. Core technologies: All-in-one dry chemistry technology and non-enhancement time-resolved fluorometry (TRF). Categories of activity: Biotech company; Production; R&D; R&D service; Other service; Supplier; Diagnostics and devices; |
Invenire Market Intelligence Oy
Pharmacity, Itäinen pitkäkatu 4 B, FI-20520 Turku, Finland
Web site: www.invenire.fi
Founded: 2003 | Patricia Wiklund, Director, Business Development
Phone: +358 (0)2 4788 620
Fax: +358 (0)2 4788 120
patricia.wiklund(at)invenire.fi Markus Orava, CEO
Phone: +358 (0)2 4788 620
Fax: +358 (0)2 4788 120
markus.orava(at)invenire.fi | Production (and other) activities: Invenire Market Intelligence is a privately owned, professional service provider working mainly within the field of life sciences. Invenire has a proven track-record of working with a number of organizations operating in various sectors of life sciences both in Finland and internationally. The Invenire consultants have backgrounds in business, academia and engineering.
Invenire supports its clients by providing:
• Business skills and knowledge
• Market research resources and skills
• Objective insight
• Understanding of the life science business
• Access and local knowledge. Categories of activity: Biotech support company; Other service; |
Ipsat Therapies Oy
Viikinkaari 4, FI-00790 Helsinki, Finland
Web site: www.ipsat-ther.com
Founded: 1999
Personnel: 19 | Nora Kaarela, CEO
Phone: +358 9 3193 6520
Fax: +358 9 3193 6519
nora.kaarela(at)ipsat-ther.com Tuula Heinonen, Director, R&D
Phone: +358 9 3193 6501
Fax: +358 9 3193 6519
tuula.heinonen(at)ipsat-ther.com | Core technologies: A drug development company focusing on antibiotic-induced bacterial resistance, hospital infections, antibiotic-indiced colitis and diarrhea. Categories of activity: Biotech company; R&D; Drug discovery; |
Jurilab Oy Ltd
Microkatu 1, FI-70210 Kuopio, Finland
Web site: www.jurilab.com
Founded: 1999
Personnel: 35 | Jukka T. Salonen, CSO
Phone: +358 207 219 200
Fax: +358 207 219 201
info(at)jurilab.com | R&D activities: Discovery and validation of gene-disease associations for therapeutic, diagnostic and nutritional applications. Core technologies: A proprietary method of identifying and verifying DNA variations, known as Hierarchical Phenotype-Targeted Sequencing (HPTS), and linking these mutations to diseases. Categories of activity: Biotech company; R&D service; Drug discovery; Diagnostics and devices; |
JVS-Polymers Inc
Innopoli, Tekniikantie 12, FI-02150 Espoo, Finland
Founded: 1994 | Dr Jukka Seppälä, Chairman of the Board
Phone: +358 9 251 73 430
Fax:
jvs(at)innopoli.fi | R&D activities: - Polymer technology and engineering
- Biopolymers technologies Core technologies: - Biodegradable polymer technologies
- Biomedical polymers Categories of activity: Biotech company; R&D; Biomaterials; |
Karyon-CTT Ltd.
Viikinkaari 6, FI-00710 Helsinki, Finland
Web site: www.karyonctt.eu
Founded: 2001
Personnel: 20 (2006) | Rabbe Slätis, President & CEO
Phone: +358 9 319 36400
Fax: +358 9 319 36415
rabbe.slatis(at)karyonctt.eu Jari-Matti Mehto, Vice President & COO
Phone: +358 9 319 36387
Fax: +358 9 319 36415
jari-matti.mehto(at)karyonctt.eu | Production (and other) activities: Karyon-CTT focuses on the development, patenting and commercialisation of tissuespecific targeting compounds for use in diagnostic imaging and therapy. Karyon-CTT'sproducts are targeting molecules intended for either diagnostic or therapeutic usein the area of oncology. R&D activities: Current R&D focuses on novel peptide-based tumour targeting units that target cancer conditions with strong angiogenic characteristics. Core technologies: Phage display techniques, recombinant DNA techniques, cell culture assays and invitro analyses, organic syntheses and analyses, protein production and purification, animal work, in vivo analyses, histology and immunohistochemistry. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; |
Kibron Inc.
Upseerinkatu 3 A, 02600 Espoo, Finland
Web site: www.kibron.com
Founded: 1994 | Jukka Kilpiö, Managing Director
Phone: +358 9 6811 920
Fax: +358 9 6811 9222
info(at)kibron.com Jana Nyrén, Marketing Director
Phone: +358 9 6811 920
Fax: +358 9 6811 9222
info(at)kibron.com | Production (and other) activities: Kibron develops and manufacturers analyzers and assays for the pharmaceutical and chemical industries as well as academic surface chemistry research. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; Environment; Research reagents; |
Kuopio Innovation Ltd
PO Box 1188, Microkatu 1, FIN-70211 Kuopio, Finland
Web site: www.teknia.fi
Founded: 1987
Turnover: EUR 4.3 million (2005)
Personnel: 27 | Hannu Janhunen, Managing Director
Phone: +358 17 441 2001 and
Fax: +358 17 441 2011
hannu.janhunen(at)teknia.fi Minna Hendolin, Development Director
Phone: +358 17 441 2027 and
Fax: +358 17 441 2011
minna.hendolin(at)teknia.fi | Production (and other) activities: Technology Centre Teknia Ltd is an enterprise service organization, which provides professional high-quality services to technology enterprises.Teknia is responsible for coordinating technology expertise in the Kuopio region. There are over 190 companies and organisations (2000 employees) working under the umbrella of Technology Centre. Many of these companies are commercially exploiting fundamental discoveries and innovations made in the research laboratories of Kuopio University and the other research institutes in the Science Park.
Teknia is responsible for coordinating national Centre of Expertise Programme in Kuopio region (pharmaceutical development, agrobiotechnology and healthcare technology) Categories of activity: Biotech support company; Biotech centre; R&D service; Other service; Drug discovery; Diagnostics and devices; Biomaterials; Bioinformatics; Food and feed; Agro; Environment; Enzymes; |
LAB Pharma Oy
PO Box 980, FIN-20101 Turku, Finland
Web site: www.labinc.fi
Personnel: 42 (2004) | Taneli Jouhikainen, President
Phone: +358 40 544 9532
Fax: + 358 2 333 3444
taneli.jouhikainen(at)labinc.fi Bastiaan J. de Leeuw, Vice President, Business Development and Strategy
Phone: +44 79 4135 6562
Fax: +358 2 333 3444
bas.deleeuw(at)labinc.fi | Production (and other) activities: Production Rapid scaling-up of the manufacturing processes during the clinical phases of development.Production unit is part of 12,000 square metre facility. R&D activities: Expertise in carrier based dry powder formulation technologies including wet suspension technology with ultrasound processing produces highly homogeneous and physically stable powder formulations. Core technologies: LAB Pharma Oy offers an integrated product development partnership. Technology platform comprises patended powder formulations, approved TAIFUN inhaler and customised manufacturing technologies. Categories of activity: Biotech company; Production; R&D; Drug discovery; Diagnostics and devices; |
Labmaster Oy
Fiskarsinkatu 11, FI-20750 Turku, Finland
Web site: www.labmaster.fi
Founded: 1986
Personnel: 9 | Teppo Laaksonen, Managing Director
Phone: +358 2 276 0556
Fax: +358 2 276 0550
teppo.laaksonen(at)labmaster.fi | Production (and other) activities: Development, manufacturing and marketing of immunodiagnostic kits and reagents for applications in functional food research (metabolic end products of lignans and isoflavonoids) and routine clinical diagnostics (coeliac disease, osteoporosis, cardiac diseases). R&D activities: Labmaster Oy is developing new technology for clinical, biochemical and chemical analysis like also PCR analysis based on cathodic electrochemiluminescence (ECL) and application of microelectronics. Core technologies: Time-resolved fluoroimmunoassay, ELISA, cathodic electrochemiluminescence, microfabrication of silicon. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Laborexin Oy
Holkkitie 14, PO Box 224, FI-00811 Helsinki, Finland
Web site: www.laborexin.fi
Founded: 1980
Turnover: EUR 0.8 million (2004)
Personnel: 7 (2005) | Pentti Tanskanen, M.D.
Phone: +358 9 780 633
Fax: +358 9 781 393
pentti.tanskanen(at)laborexin.fi | Production (and other) activities: The company is specializing in manufacturing and marketing first class laboratory technology and glassblowing products. In addition, we represent numerous international laboratoryglass, equipment and biotechnology companies. R&D activities: Our goal is to cocentrate in technology transfer, where innovations in the academic research are developed to put them in the practice. Core technologies: Laboratory glassblowing, equipments, DNA Electrophoresis Kits, Protein Assays, Liphophilic Ionsensitive Electrodes. Categories of activity: Biotech support company; Production; R&D service; Supplier; Diagnostics and devices; Environment; Research reagents; |
Licentia Ltd
Erottajankatu 19 B 6, FI-00130 Helsinki, Finland
Web site: www.licentia.fi
Founded: 2001
Turnover: EUR 1,5 million (2004)
Personnel: 7 | Dr Timo Törmälä, President
Phone: +358 9 6814 9570 and
Fax: +358 9 6814 9599
timo.tormala(at)licentia.fi | Production (and other) activities: Commercialization of research results and technologies (.Technology transfer). Technology and IP consulting. Categories of activity: Biotech support company; Other service; Drug discovery; Diagnostics and devices; Bioinformatics; Food and feed; Research reagents; |
Life-Science-Man Oy Ltd
Keilaranta 16, FI-02150 Espoo, Finland
Web site: www.lifescience.fi
Founded: 2002
Personnel: 5 (2004) | Anu Harkki,, Managing Director, PhD, MBA
Phone: +358 9 8133 800
Fax: +358 9 8133 828
harkki(at)lifescience.fi Anu Mehtonen, Head of Regulatory Affairs, MSc
Phone: +358 9 8133 801
Fax: +358 9 8133 828
mehtonen(at)lifescience.fi | Production (and other) activities: Business and regulatory services for life science and chemical industries. - Management consulting services - Food regulatory affairs services - Chemical registration services (REACH Management) - Clinical studies and contract research services Categories of activity: Biotech support company; R&D service; Other service; Bioinformatics; Food and feed; Agro; Environment; |
Lymphatix Ltd.
| | Categories of activity: |
Macrocrystal Oy
Ruukintie 20 F, FI-02320 Espoo, Finland
Web site: www.macrocrystal.com
Founded: 1993
Personnel: 4 | Mr Kalevi Visuri
Phone: +358 9 4555 280
Fax: +358 9 4555 280
management(at)macrocrystal.com | Production (and other) activities: Crystallization process development by contracts with biotech and pharmaceutical companies. Production of crystalline proteins for laboratory use. R&D activities: Developing macromolecule crystallization methods. Developing new reagents for crystallization. Methods of technical handling of crystal batches. Core technologies: Crystallization of enzymes, proteins and peptides in large scale for commercial production purposes. Formulation of products on the basis of crystallization. Purification by crystallization. Categories of activity: Biotech company; Production; R&D service; Drug discovery; Biomaterials; Enzymes; Research reagents; |
Magnasense Ltd
Nanoscience Center, Survontie 9, FI-40500 JKL, Finland
Web site: www.magnasense.com
Founded: 2003
Personnel: 5 | Mika Laitinen, CEO
Phone: +358 40 5435989
Fax:
mika.laitinen(at)magnasense.com Jari Salmela, R&D Manager
Phone:
Fax:
jari.salmela(at)magnasense.com | R&D activities: Development of magnetometric lateral flow assay reader is going on. Magnasense also participates several research projects in the areas of magnetic particles and microfluidistics. Core technologies: Magnasense technology is based on the use of magnetic microspheres as labels and on the measurement of change on magnetization in the capture zone of a test. The diagnostic measuring instrument forms an easy to use quantitative biosensor when combined with disposable test cartridges. Either traditional sandwich assay or competitive assay formats can be used to form the capture zone.
Detection method is suitable for e.g. proteins, steroids, drugs of abuse, nucleic acids, bacteria and viruses. Categories of activity: Biotech company; R&D service; Supplier; Diagnostics and devices; |
Maininki PTC Oy
Kulttuuritehdas Korjaamo, Töölönkatu 51 B, FI-00250 Helsinki, Finland
Web site: www.maininki.com
Founded: 2004 | Sirpa Pietilä, CEO
Phone: +358 40 556 5268
Fax: +358 20 7417 001
sirpa.pietila(at)maininki.com | Production (and other) activities: Maininki PTC is specialized in effective communication and informative campaigns. Maininki PTC has special knowledge in biotechnology and is for example in charge of the national www.bioteknologia.info campaign. Categories of activity: Biotech support company; Other service; |
MAP Medical Technologies Oy
| | Categories of activity: |
Mariachi Oy
Fiskarsinkatu 11, FI-20750 Turku, Finland
Web site: www.mariachi.fi
Founded: 2008
Turnover: EUR 4 million (2008)
Personnel: 40 (2008) | Jukka Järvi-Laturi, Chairman
Phone: +358 400 824549
Fax: +358 2 2530711
jukka.jarvi-laturi(at)mariachi.fi Pasi Hatakka, Managing Director
Phone: +358 40 5401634
Fax: +358 2 2530711
pasi.hatakka(at)mariachi.fi | Production (and other) activities: Contract development and manufacturing of electronics for devices and instruments. R&D activities: R&D services include concept design, mechanical design, embedded HW and SW design and NPI including prototypes. Core technologies: Electronics. Categories of activity: Biotech support company; Production; R&D service; Diagnostics and devices; |
MCA Research Laboratory Ltd
BioCity, Tykistökatu 6 B, FI-20520 Turku, Finland
Web site: www.mcaresearchlaboratory.com
Founded: 1992
Personnel: 4 (2006) | Markku Ahotupa, Chairman of the Board
Phone: +358 2 241 0142
Fax: +358 2 241 0143
res.lab(at)mca.inet.fi | Production (and other) activities: Biochemical and toxicological research services (laboratory studies and consulting) for industry and research institutions. R&D activities: Oxidative stress related diseases. Core technologies: Testing of antioxidant activity: from in vitro models to human studies. Availability of biomarkers for lipid, protein and DNA oxidation. Categories of activity: Biotech company; Biotech support company; R&D service; Supplier; Drug discovery; Diagnostics and devices; Food and feed; Environment; |
Meda Oy
| | Categories of activity: |
Medeia Therapeutics Oy
Microkatu 1, FI-70211 Kuopio, Finland
Web site: www.medeiatherapeutics.com
Founded: 2006 | Milla Koistinaho, CEO
Phone: +358-44-590 0603
Fax: +358-44-659 00603
milla.koistinaho(at)medeiatherapeutics.com | Categories of activity: Biotech company; R&D; Drug discovery; |
Medical Interscience Talents M.I.T. Consulting Ltd
PO Box 16, FI-00601 Helsinki, Finland
Web site: www.mitconsulting.fi
Founded: 1989
Turnover: EUR 0,2 million (2005)
Personnel: 2 (2005) | Esa Soppi, President, CEO
Phone: + 358 40 524 2728
Fax: + 358 9 728 7064
esa.soppi(at)co.inet.fi | Production (and other) activities: Medical Interscience Talents M.I.T. Consulting Ltd “Doing things that stand viewing and reviewing in the arena of life sciences” provides services creating of added business value and hands on operational execution, as well as state of art methodology and innovative customized solutions to resolve challenging customer problems.
Strategy & operations:
1) Strategy audit & strategy development, 2) Portfolio and project assessment & value maximation, 3) Research & opportunity assessment, 4)Operative performance& process excellence.
Development services:
1) Refinement of drug & device development process, 2) Risk assessment & management, 3) CRO & central laboratory contracting, 4) SOP management process.
Core technologies: Proprietary methodology for portfolio management and valuation/value creation. Categories of activity: Biotech support company; R&D service; |
MediCel Oy
Haartmaninkatu 8, FIN-00290 Helsinki, Finland
Web site: www.medicel.com
Founded: 2001
Personnel: 45 (2005) | Risto Renkonen, Managing Director
Phone: +358 9 1912 5111 and
Fax: +358 9 1912 5155
risto.renkonen(at)helsinki.fi | R&D activities: MediCel's Systems Biology software development aims to gather, sort, analyse and understand the wide diversity of biological data from various pre-existing databases as well as from our own biological experiments. We also annotate and generate systematically the biochemical pathways and finally convert the huge amount of biological data into knowledge. This will allow us to generate models of biological processes, which could be further tested and iterated by both in vitro, ex vivo and in vivo experiments. Categories of activity: Biotech company; R&D; Bioinformatics; |
Medifiq Healthcare Corporation
Äyritie 8 B, FI-01510 Vantaa, Finland
Web site: www.medifiq.com
Founded: 2006
Turnover: EUR 53 million (2005)
Personnel: 450 (2005) | Tomi Karvo, VP, Sales and Marketing
Phone: +358 40 544 9528
Fax: +358 (0)56291130
tomi.karvo(at)medifiq.com Juha Laiho, Manager, Technology development
Phone: +358 40 52 51296
Fax: +358 (0)9 56291130
juha.laiho(at)medifiq.com | Production (and other) activities: Medifiq is a leading solution provider for the healthcare industry. With proven expertise in product design, tooling, assembly and manufacturing, Medifiq is able to provide its customers only with the very best subcontracting solutions, always with optimum speed and reliability. R&D activities: High speed manufacturing of precision components and assemblies, materials application development, increasing the integration level of components Core technologies: Concept design, industrialization and mechanical design, prototyping and tooling, high volume precision injection moulding and assembly in clean room environment, filling and final packaging, logistics Categories of activity: Biotech company; Biotech support company; Production; R&D service; Supplier; Diagnostics and devices; |
MediFront Ltd.
Tykistökatu 6 B, FIN-20520 Turku, Finland
Web site: www.medifront.fi
Founded: 1999
Personnel: 3 | Tapio Rautaoja, Marketing Director
Phone: +358 2 4699254
Fax: +358 2 4699255
tapio.rautaoja(at)medifront.fi | Production (and other) activities: Markets special pharmaceuticals like orphan drugs to hospitals. Categories of activity: Biotech company; Supplier; Drug discovery; |
Medikalla Oy
Volttikatu 5, FI-70700 Kuopio, Finland
Web site: www.medikalla.fi
| Tuija Keinonen, Managing Director, Ph.D.Pharm.
Phone: +358 17 288 1231
Fax: +358 17 288 1249
tuija.keinonen(at)medikalla.fi Riitta Heiskanen, Marketing manager, M.Sc. (Pharm.), BBA
Phone: +358 9 8494 5715
Fax: +358 9 8494 5710
riitta.heiskanen(at)medipharmia.fi | Production (and other) activities: Contract manufacturing and packaging of pharmaceutical products
Analytical and microbiological analysis of pharmaceutical products and raw materials
Clinical research for the pharmaceutical industry and other health care companies
Regulatory affairs for the pharmaceutical industry R&D activities: Research and development of pharmaceutical products Categories of activity: Production; R&D service; Other service; |
MediPharmia Finland
| Tuija Keinonen (Ph.D.Pharm.), Managing Director
Phone: +358 17 288 1231
Fax:
tuija.keinonen(at)medikalla.fi Riitta Heiskanen (M.Sc.Pharma., BBA), Marketing Director
Phone: +358 9 8254 0319
Fax:
riitta.heiskanen(at)medipharmia.fi | Production (and other) activities: Contract manufactoring and packaging of pharmaceutical products. Analytical and microbiological analysis of pharmaceutical products and raw materials. R&D activities: Research and development of pharmaceuticals products. Categories of activity: Biotech company; Production; R&D service; |
Medipolis GMP Oy
Kiviharjuntie 2, FI-90220 Oulu, Finland
Web site: www.medipolisgmp.com
Founded: 2001
Turnover: EUR 1 million
Personnel: 15 (2005) | Dr. Ashesh Kumar, Director
Phone: +358 400 207 380
Fax:
kumar.ashesh(at)medipolisgmp.com | Production (and other) activities: Medipolis GMP Ltd is a CMO that offers process development, fermentation, downstream and spporting QA / QC services for companies that need manufacturing of biopharmaceuticals for preclinical, clinical trials and even commercial purposes. We are looking for parters in EU for FP-7 program and offer our excellent team for process development and GMP material production for Clinical studies R&D activities: BioPAT- Process Development, Clinical Development of Biopharmaceuticals Core technologies: Microbial fermentation with related process development and downstream processes. Categories of activity: Biotech company; Production; |
Medix Biochemica Oy Ab
Asematie 13 , FI-02700 Kauniainen, Finland
Web site: www.medixbiochemica.com
Founded: 1985
Turnover: EUR 9,1 million (2006)
Personnel: 90 (2006) | Mr. Ismo Råman, Managing Director
Phone: +358 9 547680
Fax: +358 9 5053441
ismo.raman(at)medixbiochemica.com | Production (and other) activities: Production Monoclonal antibodies and rapid diagnostic tests. R&D activities: Monoclonal antibodies and rapid diagnostic tests. Core technologies: Antibody technology and applications. Categories of activity: Biotech company; Production; R&D; Diagnostics and devices; |
Melius Pharma Oy
| | Categories of activity: |
Merilkon Oy / Thomson
Metsänneidonkuja 12, FI-02130 Espoo, Finland
Web site: www.merilkon.fi
Founded: 1995
Personnel: 3 (2006) | Ilkka Lakoma, Managing Director
Phone: +358 9 549 12400
Fax: +358 9 549 12405
ilkka.lakoma(at)merilkon.fi Päivi Pennanen, Partner
Phone: +358 9 549 12400
Fax: +358 9 549 12405
paivi.pennanen(at)merilkon.fi | Production (and other) activities: Thomson Business Intelligence and Thomson Dialog Services are world leaders in providing information to the management and professionals in the biotechnology and pharmaceutical industry, offering comprehensive, global coverage of biomedical research, market research, competitive analysis, news, patents and regulations.
Your industry specific information sources are indexed to enable you to pinpoint the business-critical info |